Monoclonal antibody therapy demonstrates increased virulence of a lineage VII strain of Lassa virus in nonhuman primates

References

• World Health Organization. WHO coronavirus (COVID-19) dashboard [cited 2023 Dec 08]. Available from: https://covid19.who.int/.
   Google Scholar
• Garry RF. Lassa fever—the road ahead. Nat Rev Microbiol. 2023;21:87–96. doi: 10.1038/s41579-022-00789-8
   PubMed Web of Science ®Google Scholar
• Hensley LE, Smith MA, Geisbert JB, et al. Pathogenesis of Lassa fever in cynomolgus macaques. Virol J. 2011;8:205. doi: 10.1186/1743-422X-8-205
   PubMed Web of Science ®Google Scholar
• Coyle AL. Lassa fever. Nursing. 2016;46:69–70. doi: 10.1097/01.NURSE.0000482873.70955.7b
   PubMedGoogle Scholar
• Simons D. Lassa fever cases suffer from severe underreporting based on reported fatalities. Int Health. 2022;15(5):608–610.
   Web of Science ®Google Scholar
• World Health Organization. Lassa fever [cited 2023 Jul 18]. Available from: https://www.who.int/health-topics/lassa-fever#tab=tab_1.
   Google Scholar
• Shaffer JG, Grant DS, Schieffelin JS, et al. Lassa fever in post-conflict Sierra Leone. PLoS Negl Trop Dis. 2014;8:e2748. doi: 10.1371/journal.pntd.0002748
   PubMed Web of Science ®Google Scholar
• Wolf T, Ellwanger R, Goetsch U, et al. Fifty years of imported Lassa fever: a systematic review of primary and secondary cases. J Travel Med. 2020;27(4):1–11. doi: 10.1093/jtm/taaa035
   Web of Science ®Google Scholar
• Mateer EJ, Huang C, Shehu NY, et al. Lassa fever-induced sensorineural hearing loss: a neglected public health and social burden. PLoS Negl Trop Dis. 2018;12:e0006187. doi: 10.1371/journal.pntd.0006187
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2018 annual review of diseases prioritized under the Research and Development Blueprint [cited 2021 Nov 22]. Available from: https://www.who.int/blueprint/priority-diseases/en/.
   Google Scholar
• Coalition for Epidemic Preparedness Innovations. Priority diseases [cited 2023 Jul 18]. Available from: https://cepi.net/research_dev/priority-diseases/.
   Google Scholar
• World Health Organization. Target product profile for Lassa virus vaccine [cited 2023 Aug 02]. Available from: https://lassafever.info/resources/who-target-product-profile-lassa-virus-vaccine#:~:text=Lassa%20virus%20vaccine-,WHO%3A%20Target%20product%20profile%20for%20Lassa%20virus%20vaccine,for%20Action%20to%20Prevent%20Epidemics.
   Google Scholar
• Salami K, Gsell P-S, Olayinka A, et al. Meeting report: WHO consultation on accelerating Lassa fever vaccine development in endemic countries, Dakar, 10–11 September 2019. Vaccine. 2020;38:4135–4141. doi: 10.1016/j.vaccine.2020.01.017
   PubMed Web of Science ®Google Scholar
• Bowen MD, Rollin PE, Ksiazek TG, et al. Genetic diversity among Lassa virus strains. J Virol. 2000;74:6992–7004. doi: 10.1128/JVI.74.15.6992-7004.2000
   PubMed Web of Science ®Google Scholar
• Manning JT, Forrester N, Paessler S. Lassa virus isolates from Mali and the Ivory Coast represent an emerging fifth lineage. Front Microbiol. 2015;6:1037. doi: 10.3389/fmicb.2015.01037
   PubMed Web of Science ®Google Scholar
• Olayemi A, Cadar D, Magassouba N, et al. New hosts of the Lassa virus. Sci Rep. 2016;6:25280. doi: 10.1038/srep25280
   PubMed Web of Science ®Google Scholar
• Whitmer SLM, Strecker T, Cadar D, et al. New lineage of Lassa virus, Togo, 2016. Emerg Infect Dis. 2018;24:599–602. doi: 10.3201/eid2403.171905
   PubMed Web of Science ®Google Scholar
• Ibukun FI. Inter-lineage variation of Lassa virus glycoprotein epitopes: a challenge to Lassa virus vaccine development. Viruses. 2020;12:386. doi: 10.3390/v12040386
   PubMed Web of Science ®Google Scholar
• Yadouleton A, Picard C, Rieger T, et al. Lassa fever in Benin: description of the 2014 and 2016 epidemics and genetic characterization of a new Lassa virus. Emerg Microbes Infect. 2020;9:1761–1770. doi: 10.1080/22221751.2020.1796528
   PubMed Web of Science ®Google Scholar
• Cross RW, Xu R, Matassov D, et al. Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death. J Clin Invest. 2020;130:539–551. doi: 10.1172/JCI131958
   PubMed Web of Science ®Google Scholar
• Mateo M, Reynard S, Journeaux A, et al. A single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains. Sci Transl Med. 2021;13(597):1–19. doi: 10.1126/scitranslmed.abf6348
   Web of Science ®Google Scholar
• Cross RW, Woolsey C, Prasad AN, et al. A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa fever. Cell Rep. 2022;40:111094. doi: 10.1016/j.celrep.2022.111094
   PubMed Web of Science ®Google Scholar
• Robinson JE, Hastie KM, Cross RW, et al. Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits. Nat Commun. 2016;7:11544. doi: 10.1038/ncomms11544
   PubMed Web of Science ®Google Scholar
• Cross RW, Mire CE, Branco LM, et al. Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies. Antiviral Res. 2016;133:218–222. doi: 10.1016/j.antiviral.2016.08.012
   PubMed Web of Science ®Google Scholar
• Mire CE, Cross RW, Geisbert JB, et al. Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever. Nat Med. 2017;23:1146–1149. doi: 10.1038/nm.4396
   PubMed Web of Science ®Google Scholar
• Cross RW, Heinrich ML, Fenton KA, et al. A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus. Proc Natl Acad Sci. 2023;120:e2304876120. doi: 10.1073/pnas.2304876120
   PubMedGoogle Scholar
• Baillet N, Reynard S, Perthame E, et al. Systemic viral spreading and defective host responses are associated with fatal Lassa fever in macaques. Commun Biol. 2021;4:27. doi: 10.1038/s42003-020-01543-7
   PubMed Web of Science ®Google Scholar
• Woolsey C, Borisevich V, Agans KN, et al. Bundibugyo ebolavirus survival is associated with early activation of adaptive immunity and reduced myeloid-derived suppressor cell signaling. mBio. 2021;12:e0151721. doi: 10.1128/mBio.01517-21
   PubMed Web of Science ®Google Scholar
• Mateo M, Hortion J, Perthame E, et al. Pathogenesis of recent Lassa virus isolates from lineages II and VII in cynomolgus monkeys. Virulence. 2022;13:654–669. doi: 10.1080/21505594.2022.2060170
   PubMed Web of Science ®Google Scholar
• Stein DR, Warner BM, Audet J, et al. Differential pathogenesis of closely related 2018 Nigerian outbreak clade III Lassa virus isolates. PLoS Path. 2021;17:e1009966. doi: 10.1371/journal.ppat.1009966
   PubMed Web of Science ®Google Scholar
• Safronetz D, Strong JE, Feldmann F, et al. A recently isolated Lassa virus from Mali demonstrates atypical clinical disease manifestations and decreased virulence in cynomolgus macaques. J Infect Dis. 2013;207:1316–1327. doi: 10.1093/infdis/jit004
   PubMed Web of Science ®Google Scholar
• Geisbert TW, Daddario-DiCaprio KM, Geisbert JB, et al. Marburg virus Angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant protein c2. J Infect Dis. 2007;196(Suppl 2):S372–S381. doi: 10.1086/520608
   PubMedGoogle Scholar
• Fernando L, Qiu X, Melito PL, et al. Immune response to Marburg virus Angola infection in nonhuman primates. J Infect Dis. 2015;212(Suppl 2):S234–S241.
   PubMedGoogle Scholar
• Mire CE, Satterfield BA, Geisbert JB, et al. Pathogenic differences between Nipah virus Bangladesh and Malaysia strains in primates: implications for antibody therapy. Sci Rep. 2016;6:30916. doi: 10.1038/srep30916
   PubMed Web of Science ®Google Scholar
• Raabe V, Mehta AK, Evans JD, et al. Lassa virus infection: a summary for clinicians. Int J Infect Dis. 2022;119:187–200. doi: 10.1016/j.ijid.2022.04.004
   PubMed Web of Science ®Google Scholar
• Walker KW, Salimi-Moosavi H, Arnold GE, et al. Pharmacokinetic comparison of a diverse panel of non-targeting human antibodies as matched IgG1 and IgG2 isotypes in rodents and non-human primates. PLoS One. 2019;14:e0217061.
   PubMed Web of Science ®Google Scholar
• Ma Y, Zhang Y, Zhu L. Role of neutrophils in acute viral infection. Immun Inflamm Dis. 2021;9:1186–1196. doi: 10.1002/iid3.500
   PubMed Web of Science ®Google Scholar
• Rathore AP, St John AL. Protective and pathogenic roles for mast cells during viral infections. Curr Opin Immunol. 2020;66:74–81. doi: 10.1016/j.coi.2020.05.003
   PubMed Web of Science ®Google Scholar
• Prescott JB, Marzi A, Safronetz D, et al. Immunobiology of Ebola and Lassa virus infections. Nat Rev Immunol. 2017;17:195–207. doi: 10.1038/nri.2016.138
   PubMed Web of Science ®Google Scholar
• Klitting R, Kafetzopoulou LE, Thiery W, et al. Predicting the evolution of the Lassa virus endemic area and population at risk over the next decades. Nat Commun. 2022;13:5596. doi: 10.1038/s41467-022-33112-3
   PubMed Web of Science ®Google Scholar
• Cross RW, Bornholdt ZA, Prasad AN, et al. Combination therapy protects macaques against advanced Marburg virus disease. Nat Commun. 2021;12:1891. doi: 10.1038/s41467-021-22132-0
   PubMed Web of Science ®Google Scholar
• Cross RW, Bornholdt ZA, Prasad AN, et al. Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease. JCI Insight. 2022;7(10):1–14. doi: 10.1172/jci.insight.159090
   Web of Science ®Google Scholar
• Geisbert TW, Jones S, Fritz EA, et al. Development of a new vaccine for the prevention of Lassa fever. PLoS Med. 2005;2:e183. doi: 10.1371/journal.pmed.0020183
   PubMed Web of Science ®Google Scholar
• Prasad AN, Woolsey C, Geisbert JB, et al. Resistance of cynomolgus monkeys to Nipah and Hendra virus disease is associated with cell-mediated and humoral immunity. J Infect Dis. 2020;221:S436–S447. doi: 10.1093/infdis/jiz613
   PubMed Web of Science ®Google Scholar
• Woolsey C, Cross RW, Agans KN, et al. A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge. PLoS Negl Trop Dis. 2022;16:e0010433. doi: 10.1371/journal.pntd.0010433
   PubMed Web of Science ®Google Scholar
• Woolsey C, Fears AC, Borisevich V, et al. Natural history of Sudan ebolavirus infection in rhesus and cynomolgus macaques. Emerg Microbes Infect. 2022;11:1635–1646. doi: 10.1080/22221751.2022.2086072
   PubMed Web of Science ®Google Scholar